Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1N acetyl cysteine1件: Cysteine---1件: 19 💬
2N Acetyl L Leucine1件: Leucine1件: Leucine 💬 --1件: 19 💬
3N(4,5Bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate1件: Guanidine---1件: 113 💬
4N,N,N',N'-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬 --1件: 127 💬
5N,N,N?,N?-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬 --1件: 127 💬
6N,N,N’,N’-tetramethyl-10H-phenothiazine-3,7-diaminium bis(methanesulfonate)1件: Phenothiazine1件: Phenothiazine 💬 --1件: 127 💬
7N-(4,5-Bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate1件: Guanidine---1件: 113 💬
8N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----1件: 299 💬
9N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----1件: 299 💬
10N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide----1件: 49 💬
11N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----1件: 299 💬
12N-0923----1件: 6 💬
13N-3 LC-PUFA----1件: 46 💬
14N-3 Polyunsaturated Fatty Acids----1件: 96 💬
15N-[1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl]-2-[4-(1-(trifluoromethyl)cyclopropyl)phenyl]acetamide2件: Acetamide,
Pyrazole		---1件: 154 💬
16N-acetyl cysteine1件: Cysteine---6件: 13, 34, 85, 88, 296, 310 💬
17N-Acetyl Cysteine (NAC)1件: Cysteine---1件: 90 💬
18N-acetyl-cysteine1件: Cysteine---1件: 84 💬
19N-Acetyl-L Leucine1件: Leucine1件: Leucine 💬 --1件: 19 💬
20N-Acetyl-L-Leucine2件: L-Acetylleucine,
Leucine		1件: Leucine 💬 --2件: 19, 65 💬
21N-acetylcystein----1件: 299 💬
22N-Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337 💬
23N-acetylcysteine (NAC)1件: Acetylcysteine1件: Acetylcysteine 💬 --2件: 51, 299 💬
24N-acetylcysteine capsule1件: Acetylcysteine1件: Acetylcysteine 💬 --1件: 6 💬
25N-acetylcysteine syrup1件: Acetylcysteine1件: Acetylcysteine 💬 --1件: 53 💬
26N-Acetylcysteine, (NAC)1件: Acetylcysteine1件: Acetylcysteine 💬 --1件: 85 💬
27N-acetylgalactosamine 4-sulfatase----1件: 19 💬
28N-acetylneuraminic acid----1件: 30 💬
29N-Carbamylglutamate1件: Carglumic acid1件: Carglumic acid 💬 1件: CPS1 💬 6件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism 💬2件: 245, 246 💬
30N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium----1件: 28 💬
31N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----1件: 13 💬
32N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate2件: Acetate,
Somatotropin		---1件: 265 💬
33N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium----1件: 96 💬
34N-{4-Chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium----1件: 96 💬
35N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----1件: 11 💬
36N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE5件: Aluminium,
Aluminum hydroxide,
Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein,
Hydroxide ion		1件: Aluminum hydroxide 💬 --1件: 11 💬
37N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14 💬
38N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM1971件: Corynebacterium diphtheriae CRM197 protein---1件: 13 💬
39N.a.----10件: 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 💬
40N.d.----1件: 97 💬
41N02BG10----1件: 13 💬
42N03AX12----1件: 13 💬
43N04BA----1件: 6 💬
44N04BC07----1件: 6 💬
45N04BD02----1件: 6 💬
46N06DX01----1件: 13 💬
47N1,N3-BIS(2-MERCAPTOETHYL) ISOPHTHALAMIDE----2件: 5, 17 💬
48N6022----1件: 299 💬
49N91115----1件: 299 💬
50Na----3件: 36, 46, 85 💬
51Na18F----1件: 13 💬
52Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin)1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 86 💬
53NABILONE1件: Nabilone1件: Nabilone 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 6, 13, 127 💬
54Nabilone 0.25 mg1件: Nabilone1件: Nabilone 💬 2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 6 💬
55Nabiximols1件: Nabiximols1件: Nabiximols 💬 --1件: 13 💬
56Nabiximols - Sativex3件: Cannabidiol,
Dronabinol,
Nabiximols		3件: Dronabinol ,
Nabiximols ,
Cannabidiol 💬 		2件: CNR1,
CNR2 💬 		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
57NAC----4件: 51, 85, 90, 299 💬
58NAC effervescent tablets----1件: 90 💬
59NaCl----1件: 227 💬
60NaCl 0.9%----1件: 39 💬
61Nacom----1件: 6 💬
62NACOM 100----1件: 6 💬
63NACOM levodopa+cardidopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
64Nacystelyn----1件: 299 💬
65Nacystelyn®----1件: 299 💬
66NADH1件: NADH---1件: 302 💬
67Nadolol1件: Nadolol1件: Nadolol 💬 2件: ADRB1,
ADRB2 💬 		11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
68Naglazyme1件: Galsulfase1件: Galsulfase 💬 1件: ARSB 💬 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
69Naglazyme (galsulfase)1件: Galsulfase1件: Galsulfase 💬 1件: ARSB 💬 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
70Naglazyme®1件: Galsulfase1件: Galsulfase 💬 1件: ARSB 💬 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
71NAL----2件: 6, 299 💬
72Nalbuphine1件: Nalbuphine1件: Nalbuphine 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
73Nalbuphine ER1件: Nalbuphine1件: Nalbuphine 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
74Nalbuphine Extended-Realease (ER) Tablets1件: Nalbuphine1件: Nalbuphine 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
75Nalbuphine Extended-Release (ER) Tablets1件: Nalbuphine1件: Nalbuphine 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
76NALBUPHINE HYDROCHLORIDE1件: Nalbuphine1件: Nalbuphine 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 85 💬
77Nalmefene1件: Nalmefene1件: Nalmefene 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
78Naloxone1件: Naloxone1件: Naloxone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 226 💬
79NALOXONE HYDROCHLORIDE1件: Naloxone1件: Naloxone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
80NALOXONE HYDROCHLORIDE DIHYDRATE1件: Naloxone1件: Naloxone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
81Naltrexone1件: Naltrexone1件: Naltrexone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
82NALTREXONE CLORIDRATO1件: Naltrexone1件: Naltrexone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 10 💬
83NALTREXONE HYDROCHLORIDE1件: Naltrexone1件: Naltrexone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬8件: 10, 40, 41, 42, 43, 44, 45, 96 💬
84Naltrexone-HCl1件: Naltrexone1件: Naltrexone 💬 3件: OPRD1,
OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 96 💬
85NAMILUMAB1件: Namilumab---2件: 46, 84 💬
86Namilumab (MT203)1件: Namilumab---1件: 46 💬
87Namisol----2件: 13, 298 💬
88Namuscla1件: Mexiletine1件: Mexiletine 💬 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114 💬
89NAND (Neoandrographolide)----1件: 97 💬
90Nandrolone1件: Nandrolone1件: Nandrolone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 60, 85 💬
91Nandrolone Decanoate2件: Nandrolone,
Nandrolone decanoate		2件: Nandrolone decanoate ,
Nandrolone 💬 		1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 60, 85 💬
92Nanobody directed towards the human A1 domain of von Willebrand factor1件: Von Willebrand factor human---1件: 64 💬
93Nanobubble drink----1件: 46 💬
94Nanocort----3件: 13, 46, 97 💬
95Nanocurcumin----2件: 13, 271 💬
96Nanogam----1件: 63 💬
97Nanogam 100 mg/ml----1件: 65 💬
98Nanogam® 50 mg/ml----1件: 65 💬
99Nanoparticulated Rebamipide1件: Rebamipide1件: Rebamipide 💬 --1件: 46 💬
100Nanosuspension)----1件: 113 💬
101Nap----2件: 96, 240 💬
102NaPBA----1件: 251 💬
103Naprosyn1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
104Naprosyn 500 mg1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
105Naprosysn----1件: 271 💬
106Naproxen1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 107, 271 💬
107Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.)1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
108Naproxen 10 mg/kg1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
109Naproxen 500 mg tablets (PN 200 minus omeprazole)2件: Naproxen,
Omeprazole		2件: Naproxen ,
Omeprazole 💬 		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬 		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
110Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.)1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
111Naproxen oral suspension1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
112NAPROXEN SODIUM1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 107 💬
113Naproxen sodium 550mg tablet1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
114Nardil1件: Phenelzine1件: Phenelzine 💬 2件: MAOA,
MAOB 💬 		14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
115Narsoplimab1件: Narsoplimab1件: Narsoplimab 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬2件: 66, 222 💬
116Nasal Aztreonam1件: Aztreonam1件: Aztreonam 💬 --1件: 299 💬
117Nasonex----1件: 98 💬
118Nasopharyngeal swabs----1件: 46 💬
119NATALIZUMAB1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬5件: 13, 15, 25, 46, 96 💬
120Natalizumab (BG00002)1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
121Natalizumab (NTZ)1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
122Natalizumab (Tysabri)1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
123Natalizumab 300 MG in 15 ML Injection1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
124Natalizumab for IV Infusion1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
125Natalizumab for Subcutaneous Injection1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
126Natalizumab Injection [Tysabri]1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
127Natalizumab IV1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
128Natalizumab SC1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
129Natalizumab treatment1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
130National Drug Code: 59762-0074----1件: 81 💬
131Natpar1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTH2R 💬 		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
132Natpara----1件: 235 💬
133NATPARA/NATPAR1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTH2R 💬 		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
134Natriumchlorid1件: Sodium chloride1件: Sodium chloride 💬 --1件: 288 💬
135Natriumchlorid 0,9 %1件: Sodium chloride1件: Sodium chloride 💬 --1件: 288 💬
136Natriumklorid 9mg/ml----1件: 46 💬
137Natriuretic peptide----1件: 276 💬
138Natrunix----1件: 46 💬
139Navocaftor----1件: 299 💬
140NBI-5788----1件: 13 💬
141NBI-74788----1件: 81 💬
142NBI-77860----1件: 81 💬
143NBI-827104----1件: 154 💬
144NBMI----2件: 5, 17 💬
145NBT-NM108----1件: 193 💬
146NBT-NM108 (60 g/day)----1件: 13 💬
147NBTX-001----1件: 6 💬
148NC 1 cell therapy----1件: 117 💬
149NC-503 (Anti-amyloidotic (AA) Agent)----1件: 46 💬
150NCA 500mg----1件: 93 💬
151Nd----6件: 2, 6, 13, 46, 51, 97 💬
152ND-L02-s0201----1件: 85 💬
153ND-L02-s0201 for injection----1件: 85 💬
154ND0611----1件: 6 💬
155ND0612----1件: 6 💬
156ND0612 (Levodopa/Carbidopa solution)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
157ND1421----1件: 6 💬
158ND1587----1件: 6 💬
159ND1589----1件: 6 💬
160ND1590----1件: 6 💬
161ND1702----1件: 6 💬
162NDC0009-0436-01----1件: 78 💬
163NDV-3A----1件: 65 💬
164NE3107----1件: 6 💬
165NEB/01-07----1件: 299 💬
166Nebcin----1件: 299 💬
167Nebcin (tobramycin)1件: Tobramycin1件: Tobramycin 💬 --1件: 299 💬
168Nebcinal----1件: 299 💬
169Nebcinal Tobi----1件: 299 💬
170NEBCINE----1件: 299 💬
171Nebicapone1件: Nebicapone---1件: 6 💬
172Nebido----1件: 13 💬
173Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection3件: Testosterone,
Testosterone undecanoate,
Undecanoic acid		2件: Testosterone ,
Testosterone undecanoate 💬 		1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13 💬
174Nebivolol1件: Nebivolol1件: Nebivolol 💬 1件: ADRB1 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 17, 85, 113, 167 💬
175Nebivolol 5 mg1件: Nebivolol1件: Nebivolol 💬 1件: ADRB1 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17 💬
176Nebulization of Amikacin during NIV (RR: 15 cycles/minute)1件: Amikacin1件: Amikacin 💬 --1件: 299 💬
177Nebulization of Amikacin during NIV (RR: 25 cycles/minute)1件: Amikacin1件: Amikacin 💬 --1件: 299 💬
178Nebulization tobramycin1件: Tobramycin1件: Tobramycin 💬 --1件: 299 💬
179Nebulized combination ipratropium bromide with salbutamol2件: Ipratropium,
Salbutamol		1件: Albuterol 💬 1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
180Nebulized ipratropium bromide1件: Ipratropium---1件: 86 💬
181Necator americanus----1件: 13 💬
182Nedosiran----1件: 234 💬
183Needle biopsy of the vastus lateralis muscle----1件: 113 💬
184NEFECON----1件: 66 💬
185Neflamapimod1件: Neflamapimod1件: Neflamapimod 💬 4件: MAPK11,
MAPK12,
MAPK13,
MAPK14 💬 		62件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬1件: 8 💬
186NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 50 💬
187NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA1件: Triethylenetetramine---1件: 50 💬
188NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 50 💬
189Nelfinavir1件: Nelfinavir1件: Nelfinavir 💬 --3件: 49, 265, 331 💬
190Nelfinavir mesylate1件: Nelfinavir1件: Nelfinavir 💬 --1件: 265 💬
191Nelotanserin1件: Nelotanserin1件: Nelotanserin 💬 1件: HTR2A 💬 5件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬1件: 6 💬
192Nelutri™----1件: 84 💬
193Nemolizumab1件: Nemolizumab1件: Nemolizumab 💬 1件: IL31RA 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 51 💬
194Neo-ASA----1件: 251 💬
195NEO-GAA----1件: 256 💬
196Neo-Recormon----1件: 18 💬
197NEOD001----1件: 28 💬
198NeoFuse----1件: 70 💬
199NeoGAA1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬 1件: GAA 💬 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
200NeoGAA or avalglucosidase alfa1件: Avalglucosidase alfa1件: Avalglucosidase alfa 💬 1件: GAA 💬 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256 💬
201Neomycin1件: Neomycin1件: Neomycin 💬 --3件: 96, 97, 296 💬
202Neophyr 1000ppm mol/mol----1件: 294 💬
203Neoral1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 60, 97, 222 💬
204Neoral Oral Solution1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 269 💬
205Neoral Soft Gelatin Capsules2件: Cyclosporine,
Gelatin		3件: Gelatin ,
Cyclosporine ,
Donkey glue 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 97, 269 💬
206NeoRecormon1件: Erythropoietin---2件: 13, 18 💬
207Neovasculgen----1件: 51 💬
208Neramexane1件: Neramexane---1件: 13 💬
209Neramexane mesylate1件: Neramexane---1件: 13 💬
210Neratinib1件: Neratinib1件: Neratinib 💬 3件: EGFR,
ERBB2,
ERBB4 💬 		51件: Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬1件: 34 💬
211Neridronic Acid1件: Neridronic Acid---1件: 6 💬
212Nerispirdine1件: Nerispirdine---1件: 13 💬
213Nerispirdine (HP184)1件: Nerispirdine---1件: 13 💬
214Nerispirdine hydrochloride1件: Nerispirdine---1件: 13 💬
215NERIXIA*IM EV 1F 25MG----1件: 6 💬
216NERIXIA*INFUS IV CONC 2F 100MG----1件: 274 💬
217Nerve block----1件: 46 💬
218Nerve Growt Factor - 2.5S----1件: 90 💬
219Nerve Growth Factor1件: Nerve Growth Factor---3件: 3, 53, 90 💬
220Nessuno----1件: 96 💬
221Neu-120----1件: 6 💬
222Neumega (Oprelvekin, Interleukin 11, IL-11)1件: Oprelvekin1件: Oprelvekin 💬 1件: IL11RA 💬 3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬1件: 288 💬
223NEUPOGEN1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬4件: 13, 28, 51, 285 💬
224NEUPRO1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
225Neupro (Reference)1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
226NEUPRO 2 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
227Neupro 2 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
228Neupro 2mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
229Neupro 2mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
230NEUPRO 4 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
231Neupro 4 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
232Neupro 4mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
233Neupro 4mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
234Neupro 4Mg/24Hr Transdermal Patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
235NEUPRO 6 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
236Neupro 6 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
237Neupro 6mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
238Neupro 6mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
239NEUPRO 8 mg/24 h parche transdérmico1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
240Neupro 8 mg/24 h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
241Neupro 8mg/24h transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
242NEUPRO*28CER 2MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
243NEUPRO*28CER 4MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
244NEUPRO*28CER 6MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
245NEUPRO*28CER 8MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
246NEUPRO*7CER 4MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
247NEUPRO*7CER 6MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
248NEUPRO*7CER 8MG/24H1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
249Neupro®1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
250Neupro® 8 mg/24 h1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
251Neuraceq1件: Florbetaben (18F)---1件: 6 💬
252NEUROASPIS PLP10®----1件: 13 💬
253NEUROBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 6 💬
254NeuroEPO----1件: 6 💬
255Neurological evaluation----1件: 25 💬
256NEURONTIN1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
257Neurontin 300 mg hard capsule1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
258NeuroVax1件: NeuroVax---1件: 13 💬
259NeuroVax 300ug/mL Dose for IM Injection1件: NeuroVax---1件: 13 💬
260Neurpro----1件: 6 💬
261Nevanimibe1件: Nevanimibe1件: Nevanimibe 💬 --2件: 75, 81 💬
262Nevanimibe hydrochloride1件: Nevanimibe1件: Nevanimibe 💬 --2件: 75, 81 💬
263Nevirapine1件: Nevirapine1件: Nevirapine 💬 --1件: 265 💬
264New formulation adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
265New Formulation Etanercept1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬 		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
266New Formulation of rebif - human interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
267New thermo stable formulation of epoprostenol sodium1件: Epoprostenol1件: Epoprostenol 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
268NewGam----3件: 14, 63, 65 💬
269Newnorm----1件: 65 💬
270Nexavar1件: Sorafenib1件: Sorafenib 💬 8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬 		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
271Nexavar (BAY 43-9006) (Sorafenib)1件: Sorafenib1件: Sorafenib 💬 8件: BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬 		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
272Nexium1件: Esomeprazole1件: Esomeprazole 💬 2件: ATP4A,
ATP4B 💬 		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299 💬
273Nexium (esomeprazole magnesium)2件: Esomeprazole,
Magnesium		1件: Esomeprazole 💬 2件: ATP4A,
ATP4B 💬 		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 298 💬
274Nexium 201件: Esomeprazole1件: Esomeprazole 💬 2件: ATP4A,
ATP4B 💬 		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299 💬
275Next generation sequencing----1件: 171 💬
276NFC-1----1件: 203 💬
277NFX-179 Gel----1件: 34 💬
278NG-Monomethyl-L-arginine3件: Arginine,
L-arginine,
Tilarginine		1件: Arginine 💬 --1件: 67 💬
279Ng-monomethyl-L-arginine (drug)3件: Arginine,
L-arginine,
Tilarginine		1件: Arginine 💬 --1件: 67 💬
280Ngenla1件: Somatrogon1件: Somatrogon 💬 --1件: 78 💬
281NGENLA (Somatrogon)1件: Somatrogon1件: Somatrogon 💬 --1件: 78 💬
282NGM282----2件: 93, 94 💬
283NGN-101----1件: 19 💬
284NGX2671件: NGX267---1件: 53 💬
285NI-0101----1件: 46 💬
286NI-03----1件: 298 💬
287NI-0401 (anti-CD3 mAB)1件: Muromonab---1件: 96 💬
288NI-0501----1件: 107 💬
289NI-071----1件: 46 💬
290NI-0801----1件: 93 💬
291Niacin1件: Niacin1件: Niacin 💬 --2件: 6, 78 💬
292Niacin First1件: Niacin1件: Niacin 💬 --1件: 78 💬
293Niacinamide1件: Nicotinamide1件: Niacinamide 💬 --3件: 5, 6, 67 💬
294Nicardipine1件: Nicardipine1件: Nicardipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 70, 86 💬
295Niclosamide1件: Niclosamide1件: Niclosamide 💬 --2件: 46, 97 💬
296Nicolon----1件: 97 💬
297Nicorette 10mg/ 16 h1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
298Nicorette 15 mg/ 16 h1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
299Nicorette 5 mg/ 16 h1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
300Nicotinamid riboside----1件: 13 💬
301Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --8件: 2, 6, 18, 49, 97, 107, 162, 191 💬
302Nicotinamide riboside2件: Nicotinamide,
Nicotinamide riboside		1件: Niacinamide 💬 --5件: 2, 6, 18, 97, 191 💬
303Nicotinamide Riboside Chloride3件: Chloride ion,
Nicotinamide,
Nicotinamide riboside		1件: Niacinamide 💬 --1件: 97 💬
304NICOTINE1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬3件: 6, 13, 84 💬
305Nicotine dependence1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 13 💬
306Nicotine gum1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
307Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
308Nicotine patch1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬2件: 6, 84 💬
309Nicotine transdermal patch1件: Nicotine1件: Nicotine 💬 16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 6 💬
310Nicotinell----1件: 6 💬
311Nicotinell 17,5 mg/24-Stunden-Pflaster----1件: 6 💬
312Nicotinell 35 mg/24-Stunden-Pflaster----1件: 6 💬
313Nicotinic acid1件: Niacin1件: Niacin 💬 --1件: 79 💬
314Nifedipine1件: Nifedipine1件: Nifedipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 50, 81 💬
315Nifurtimox1件: Nifurtimox1件: Nifurtimox 💬 --1件: 65 💬
316Nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d2件: Eflornithine,
Nifurtimox		2件: Nifurtimox ,
Eflornithine 💬 		1件: ODC1 💬 3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65 💬
317Nifurtimox-Eflronithine Combination Treatment (NECT)1件: Nifurtimox1件: Nifurtimox 💬 --1件: 65 💬
318Nilotinib1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬5件: 6, 8, 34, 51, 86 💬
319Nilotinib (Tasigna)1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 51 💬
320Nilotinib 150 MG1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 8 💬
321Nilotinib 150mg oral capsule [Tasigna]1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
322Nilotinib 300mg oral capsule [Tasigna]1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 6 💬
323Nilotinib 50 mg1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
324NILOTINIB HYDROCHLORIDE MONOHYDRATE1件: Nilotinib1件: Nilotinib 💬 4件: ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
325Nilvadipine1件: Nilvadipine1件: Nilvadipine 💬 4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 90 💬
326Nimenrix9件: Clostridium tetani toxoid antigen (formaldehyde inactivated),
Meningococcal polysaccharide vaccine group A,
Meningococcal polysaccharide vaccine group C,
Meningococcal polysaccharide vaccine group W-135,
Meningococcal polysaccharide vaccine group Y,
Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigen,
Neisseria meningitidis group C capsular polysaccharide tetanus toxoid conjugate antigen,
Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen,
Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen		2件: Meningococcal polysaccharide vaccine group A ,
Meningococcal polysaccharide vaccine group C 💬 		--2件: 50, 61 💬
327Nimesulide1件: Nimesulide1件: Nimesulide 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
328Ninlaro1件: Ixazomib1件: Ixazomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬2件: 13, 61 💬
329NINTEDANIB1件: Nintedanib1件: Nintedanib 💬 8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬5件: 51, 85, 89, 227, 228 💬
330Nintedanib 150 mg and 100 mg soft capsules1件: Nintedanib1件: Nintedanib 💬 8件: FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬 		34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬1件: 227 💬
331Nintédanib----1件: 227 💬
332NIP292 tablet----1件: 85 💬
333NIP292 tablets----1件: 85 💬
334Nipocalimab1件: Nipocalimab1件: Nipocalimab 💬 1件: FCGRT 💬 -6件: 11, 14, 46, 49, 53, 61 💬
335Nitazoxanide1件: Nitazoxanide1件: Nitazoxanide 💬 --3件: 46, 96, 97 💬
336Nitazoxanide 500Mg Oral Tablet1件: Nitazoxanide1件: Nitazoxanide 💬 --2件: 46, 97 💬
337NITISINONE1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬3件: 6, 164, 241 💬
338Nitisinone 10 mg Tablet High Compritol1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
339Nitisinone Baked Tablet1件: Nitisinone1件: Nitisinone 💬 1件: HPD 💬 5件: Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 241 💬
340Nitrate1件: Nitrate1件: Nitric acid 💬 --4件: 58, 67, 113, 299 💬
341Nitrate-depleted beetroot juice1件: Nitrate1件: Nitric acid 💬 --1件: 67 💬
342NITRIC OXIDE1件: Nitric Oxide1件: Nitric oxide 💬 --7件: 85, 86, 88, 210, 251, 294, 299 💬
343Nitric Oxide 160 ppm1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 299 💬
344Nitric Oxide for inhalation1件: Nitric Oxide1件: Nitric oxide 💬 --2件: 86, 299 💬
345Nitric Oxide generated by the GeNO nitrosyl delivery system1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 86 💬
346Nitric Oxide plus Oxygen2件: Nitric Oxide,
Oxygen		2件: Oxygen ,
Nitric oxide 💬 		--1件: 86 💬
347Nitric oxide supplement1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 251 💬
348Nitrite1件: Nitrite---2件: 58, 86 💬
349Nitrofurantoin1件: Nitrofurantoin1件: Nitrofurantoin 💬 --1件: 13 💬
350Nitrogen1件: Nitrogen1件: Nitrogen 💬 --5件: 5, 6, 17, 211, 299 💬
351Nitroglycerin1件: Nitroglycerin1件: Nitroglycerin 💬 --1件: 51 💬
352Nitroglycerin Ointment 2%1件: Nitroglycerin1件: Nitroglycerin 💬 --1件: 51 💬
353Nitroglycerine1件: Nitroglycerin1件: Nitroglycerin 💬 --2件: 46, 51 💬
354Nitroglycerine gel1件: Nitroglycerin1件: Nitroglycerin 💬 --1件: 51 💬
355Nitroprusside1件: Nitroprusside---1件: 51 💬
356Nitrosyl1件: Nitric Oxide1件: Nitric oxide 💬 --1件: 86 💬
357Nitrous Oxide1件: Nitrous oxide1件: Nitrous oxide 💬 --1件: 34 💬
358NiuBangZi pill----1件: 46 💬
359Nivolumab1件: Nivolumab1件: Nivolumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
360NIZORAL1件: Ketoconazole1件: Ketoconazole 💬 1件: CYP17A1 💬 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬1件: 75 💬
361NK Cells1件: Natural Killer Cell---1件: 26 💬
362Nle4,D-Phe7]-a-melanocyte stimulating hormone or NDP-a-MSH----1件: 254 💬
363Nle4-D-Phe7-alpha-MSH----1件: 254 💬
364NLX-112----1件: 6 💬
365NLY01----1件: 6 💬
366NM8074----2件: 62, 109 💬
367NMDA1件: Ketamine1件: Ketamine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
368NN 1841----1件: 288 💬
369NN-220----1件: 78 💬
370NN1841----1件: 288 💬
371NN8630----1件: 78 💬
372NN8640----1件: 78 💬
373NNC 0109-0000-0012----1件: 46 💬
374NNC 0141-0000-0100----1件: 46 💬
375NNC 0142-0000-0002----2件: 46, 96 💬
376NNC 0151-0000-0000----2件: 46, 49 💬
377NNC 126-0083----1件: 78 💬
378NNC 142-0002----1件: 46 💬
379NNC0109-0012----1件: 46 💬
380NNC0114-0000-0005----1件: 46 💬
381NNC0114-0006----3件: 46, 49, 96 💬
382NNC0142-0000-0002----1件: 96 💬
383NNC0142-0002----1件: 46 💬
384NNC0151-0000-0000----1件: 46 💬
385NNC0195-0092----1件: 78 💬
386NNC0195-0092 10 mg/1.5 ml PDS290-10----1件: 78 💬
387NNC0195-0092 15 mg/1.5 ml PDS290-15----1件: 78 💬
388NNC0195-0092 5 mg/1.5 ml PDS290-10----1件: 78 💬
389NNC0195-0092 DP 6.7 mg ml 3 ml cartridge----1件: 78 💬
390NNC0195-0092 PDS290 10 mg-1.5 ml----1件: 78 💬
391NNC0195-0092 PDS290 10 mg/1.5 ml----1件: 78 💬
392NNC0215-0384----2件: 46, 162 💬
393NNC109-0012----1件: 46 💬
394NNC126-00831件: Somatropin pegol---1件: 78 💬
395NNC142-0002----1件: 96 💬
396NNC151-0000----1件: 46 💬
397NNZ-2566----2件: 156, 206 💬
398NNZ-25911件: NNZ-2591---1件: 201 💬
399NO----9件: 6, 46, 58, 62, 86, 97, 222, 299, 321 💬
400Nolpitantium Besylate----1件: 97 💬
401NOMACOPAN1件: Nomacopan1件: Nomacopan 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 162 💬
402Nomacopan (rVA576)1件: Nomacopan1件: Nomacopan 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 162 💬
403Nomegestrol1件: Nomegestrol1件: Nomegestrol 💬 1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
404Nomegestrol acetate3件: Acetate,
Nomegestrol,
Nomegestrol acetate		2件: Nomegestrol ,
Nomegestrol acetate 💬 		1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
405Non applicabile----4件: 13, 49, 51, 256 💬
406Non applicable----2件: 10, 19 💬
407Non as of yet----1件: 97 💬
408Non ATG Conditioning regimen----1件: 60 💬
409NON COMMERCIAL----1件: 75 💬
410Non disponibile----1件: 201 💬
411Non intervention-Genetic testing----1件: 6 💬
412Non invasive prenatal diagnosis----3件: 8, 113, 206 💬
413NON PROPIETRY, THEREFORE N/A----1件: 51 💬
414Non-anti-TNF biologics----2件: 46, 271 💬
415Non-biologic anti-rheumatic drugs----1件: 46 💬
416Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)----1件: 46 💬
417Non-Biologic DMARDs----3件: 46, 86, 107 💬
418Non-biological DMARDs----1件: 46 💬
419Non-enteric coated pancreatic enzyme preparation----1件: 298 💬
420Non-myeloablative Hematopoietic Stem Cell Transplantation----1件: 93 💬
421Non-nucleoside reverse transcriptase inhibitors----1件: 265 💬
422Non-pegylated interferon----1件: 13 💬
423Non-steroidal anti-inflammatory drug----1件: 46 💬
424Non-steroidal anti-inflammatory drug (NSAID)----1件: 46 💬
425Non-steroidal anti-inflammatory drugs----1件: 46 💬
426Non-steroidal anti-inflammatory drugs (NSAIDs)----1件: 107 💬
427Non-TNFi-biologic class----1件: 46 💬
428Nonbiologic DMARDs of investigator's choice----1件: 46 💬
429None1件: Interleukin-1 alpha, human recombinant---20件: 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337 💬
430None as of yet1件: Interleukin-1 alpha, human recombinant---1件: 46 💬
431None assigned1件: Interleukin-1 alpha, human recombinant---2件: 231, 299 💬
432None at this time1件: Interleukin-1 alpha, human recombinant---2件: 96, 140 💬
433None given1件: Interleukin-1 alpha, human recombinant---1件: 97 💬
434None yet1件: Interleukin-1 alpha, human recombinant---2件: 51, 222 💬
435Norantipyrine----1件: 2 💬
436Nordilet®----1件: 78 💬
437Norditropin1件: Somatotropin---2件: 78, 195 💬
438Norditropin 24 IU1件: Somatotropin---1件: 195 💬
439Norditropin FlexPro 10 mg1件: Somatotropin---1件: 78 💬
440Norditropin FlexPro 10 mg/1.5 ml1件: Somatotropin---1件: 78 💬
441Norditropin FlexPro 10 mg/1.5 ml, solution for injection in pre-filled pen1件: Somatotropin---1件: 195 💬
442Norditropin FlexPro 5 mg/1.5 mL1件: Somatotropin---1件: 78 💬
443Norditropin FlexPro 5mg/1.5 ml1件: Somatotropin---1件: 78 💬
444Norditropin Growth Hormone1件: Somatotropin---1件: 78 💬
445Norditropin NordiFlex®----1件: 78 💬
446Norditropin NordiFlex® 10 mg/1.5 ml1件: Somatotropin---1件: 78 💬
447Norditropin NordiFlex® 10mg/1.5 ml1件: Somatotropin---1件: 78 💬
448Norditropin Simplex1件: Somatotropin---1件: 78 💬
449Norditropin SimpleXx1件: Somatotropin---5件: 3, 78, 107, 193, 195 💬
450Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)1件: Somatotropin---1件: 78 💬
451Norditropin SimpleXx (growth hormone)1件: Somatotropin---1件: 78 💬
452Norditropin SimpleXx 10 mg1件: Somatotropin---1件: 78 💬
453Norditropin SimpleXx 15 mg/1.5 ml1件: Somatotropin---1件: 3 💬
454Norditropin SimpleXx 5mg/1.5ml1件: Somatotropin---2件: 78, 107 💬
455Norditropine simplex----1件: 238 💬
456Norditropin®1件: Somatotropin---2件: 78, 195 💬
457Norditropin® FlexPro®----1件: 78 💬
458Norditropin® FlexPro® pen----1件: 78 💬
459Norditropin® SimpleXx® 5 mg/1.5ml1件: Somatotropin---1件: 78 💬
460Norepinephrine1件: Norepinephrine1件: Noradrenaline 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296 💬
461Norepinephrine Bitartrate1件: Norepinephrine1件: Noradrenaline 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 296 💬
462Norethindrone1件: Norethisterone1件: Norethindrone 💬 1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299 💬
463Norgestimate1件: Norgestimate1件: Norgestimate 💬 1件: PGR 💬 5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 299 💬
464Normal human immunoglobulin G1件: Human immunoglobulin G---1件: 65 💬
465Normal Saline----18件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 💬
466Normal Saline 0.9% Infusion Solution----1件: 22 💬
467Normal Saline Enema----1件: 97 💬
468Normal Saline for Injection----1件: 13 💬
469Normal saline instillation----1件: 226 💬
470Normal saline IV, salt tablets----1件: 299 💬
471Normal saline solution1件: Sodium chloride1件: Sodium chloride 💬 --1件: 299 💬
472Normal saline:----1件: 299 💬
473Normix----1件: 96 💬
474NORMIX*AD 12CPR RIV 200MG----1件: 96 💬
475Norovirus -specific T-cell (NST) therapy----1件: 65 💬
476Norphenazone1件: Edaravone1件: Edaravone 💬 --1件: 2 💬
477Norspan----1件: 46 💬
478Northera1件: Droxidopa1件: Droxidopa 💬 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
479Nortriptyline1件: Nortriptyline1件: Nortriptyline 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 226 💬
480Nortriptyline hydrochloride1件: Nortriptyline1件: Nortriptyline 💬 2件: SLC6A2,
SLC6A4 💬 		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 6 💬
481Norucholic acid1件: norUrsodeoxycholic acid---2件: 93, 94 💬
482Norucholic acid (NCA) 500 mg1件: norUrsodeoxycholic acid---1件: 93 💬
483NorUDCA----1件: 94 💬
484NorUDCA (Norursodeoxycholic acid)1件: norUrsodeoxycholic acid---1件: 94 💬
485NorUrsodeoxycholic Acid1件: norUrsodeoxycholic acid---1件: 94 💬
486Norursodeoxycholic acid, NCA1件: norUrsodeoxycholic acid---1件: 94 💬
487Norvir1件: Ritonavir1件: Ritonavir 💬 --2件: 265, 299 💬
488Norvir 100 mg film-coated tablets----1件: 299 💬
489Novamin----1件: 299 💬
490Novantrone1件: Mitoxantrone1件: Mitoxantrone 💬 2件: TOP2A,
TOP2B 💬 		1件: Platinum drug resistance 💬1件: 13 💬
491NOVANTRONE*INF 2MG/ML 5ML1件: Mitoxantrone1件: Mitoxantrone 💬 2件: TOP2A,
TOP2B 💬 		1件: Platinum drug resistance 💬1件: 13 💬
492Novartis Pharmaceuticals Corporation----1件: 13 💬
493NOVATREX----1件: 13 💬
494Novo Rapid----1件: 299 💬
495Novo Rapid Insulin (Novonordisk)----1件: 299 💬
496Novolin-R insulin----1件: 127 💬
497NovoNorm 0.5 mg----1件: 299 💬
498NovoNorm 1 mg----1件: 299 💬
499NovoNorm 2 mg----1件: 299 💬
500Novorapid / humalog short acting insulin----1件: 299 💬
501NovoRapid 100 U/ml, solution for injection in a vial. NovoRapid Penfill 100 U/ml, solution for injection in a cartridge. NovoRapid FlexPen 100 U/ml, solution for injection in a pre-filled pen.----1件: 299 💬
502NovoRapid Aspartate----1件: 299 💬
503NOX-E36----1件: 49 💬
504Noxafil1件: Posaconazole1件: Posaconazole 💬 --3件: 60, 65, 299 💬
505NOXAFIL - 40 mg/ml oral suspension1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
506NOXAFIL - 40 MG/ML SOSPENSIONE ORALE USO ORALE FLACONE (VETRO) 105 ML 1 FLACONE1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
507NOXAFIL - oral suspension 40 mg/ml1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
508Noxafil 100 mg1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
509Noxafil 100 mg Tablets Gastro-Resistant1件: Posaconazole1件: Posaconazole 💬 --1件: 299 💬
510Noxafil 40 mg/ml oral solution1件: Posaconazole1件: Posaconazole 💬 --1件: 65 💬
511Noxafil Gastro resistant tablets1件: Posaconazole1件: Posaconazole 💬 --1件: 60 💬
512Noxafil®1件: Posaconazole1件: Posaconazole 💬 --2件: 60, 299 💬
513NP001----1件: 2 💬
514NP031112----1件: 5 💬
515NP031112 600mg----1件: 5 💬
516NP031112 800mg----1件: 5 💬
517NPB-01----3件: 13, 14, 162 💬
518NPC transplantation----1件: 6 💬
519NPC-02----1件: 171 💬
520NPC-09----1件: 30 💬
521NPC-12G gel----2件: 34, 158 💬
522NPC-12Y gel----1件: 158 💬
523NPC-14----1件: 113 💬
524NPI-001----2件: 90, 303 💬
525NPL-2009----1件: 206 💬
526NPLATE1件: Romiplostim1件: Romiplostim 💬 1件: MPL 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
527NPLATE 500 microgramos polvo para solución inyectable1件: Romiplostim1件: Romiplostim 💬 1件: MPL 💬 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 63 💬
528NPSP 558----1件: 235 💬
529NPSP558----1件: 235 💬
530NR082 Injection----1件: 302 💬
531NR2B NMDA Antagonist CP-101,606 (traxoprodil)1件: Ketamine1件: Ketamine 💬 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6 💬
532NRTX-1001----1件: 141 💬
533NS----1件: 2 💬
534NS 2330----1件: 6 💬
535NS-065/NCNP-01----1件: 113 💬
536NS-089/NCNP-02----1件: 113 💬
537NS-304----3件: 70, 86, 88 💬
538NS-304 Placebo----2件: 70, 88 💬
539NS2----1件: 160 💬
540NS2330----1件: 6 💬
541NSAID----1件: 271 💬
542NSAIDs----4件: 46, 70, 107, 271 💬
543NSAIDs (permitted,not necessary)----1件: 46 💬
544NSAIDs and sulfasalazine1件: Sulfasalazine1件: Sulfasalazine 💬 --1件: 271 💬
545NsNSAIDs----2件: 107, 271 💬
546NSP001----1件: 96 💬
547NT 101----4件: 5, 6, 7, 17 💬
548NT-501----2件: 90, 303 💬
549NT-I71件: Efineptakin alfa1件: Efineptakin alfa 💬 --1件: 25 💬
550NT-KO-003----1件: 13 💬
551NTBC----1件: 241 💬
552NTCELL Implantation----1件: 6 💬
553NTLA-2001----1件: 28 💬
554NU100----1件: 13 💬
555NUCALA1件: Mepolizumab1件: Mepolizumab 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45 💬
556Nucala 100 mg powder for solution for injection1件: Mepolizumab1件: Mepolizumab 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬2件: 44, 45 💬
557NUCALA®1件: Mepolizumab1件: Mepolizumab 💬 1件: IL5 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 44 💬
558NuCel----1件: 70 💬
559NucleomaxX----1件: 265 💬
560Nucleoside analogue sparing HAART regimen----1件: 265 💬
561Nucleoside reverse transcriptase inhibitors----1件: 265 💬
562Nuedexta----1件: 2 💬
563Null----16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
564Nulojix1件: Belatacept1件: Belatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
565NurOwn (MSC-NTF cells)----2件: 2, 13 💬
566NurOwn® (MSC-NTF cells)----1件: 2 💬
567Nursinersen----1件: 3 💬
568NUSINERSEN1件: Nusinersen1件: Nusinersen 💬 1件: SMN2 💬 -1件: 3 💬
569Nusinersen Injectable Product1件: Nusinersen1件: Nusinersen 💬 1件: SMN2 💬 -1件: 3 💬
570NUSINERSEN SODIUM1件: Nusinersen1件: Nusinersen 💬 1件: SMN2 💬 -1件: 3 💬
571Nusinersen Treatments1件: Nusinersen1件: Nusinersen 💬 1件: SMN2 💬 -1件: 3 💬
572Nutraceutical Combination----1件: 96 💬
573Nutridrink-Impact----1件: 299 💬
574Nutrition supplement----1件: 97 💬
575Nutrition treat----1件: 96 💬
576Nutritional dietary intervention----2件: 96, 97 💬
577Nutritional Formulation Containing Exogenous Ketones----1件: 201 💬
578Nutritional Ketone Supplement----1件: 317 💬
579Nutritional Supplement----1件: 90 💬
580Nutritional supplementation standardized formula----1件: 78 💬
581NUTROPIN1件: Somatotropin---1件: 78 💬
582Nutropin AQ----4件: 78, 134, 193, 299 💬
583Nutropin AQ [somatropin (DNA origin) injection]1件: Somatotropin---1件: 299 💬
584NutropinAq1件: Somatotropin---1件: 78 💬
585NutropinAq 10 mg/2 ml1件: Somatotropin---1件: 78 💬
586NutropinAq 10 mg/2 ml (30 UI)1件: Somatotropin---1件: 78 💬
587NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable1件: Somatotropin---1件: 78 💬
588NutropinAq 10mg/2ml (30 I.E.) Injektionsllösung1件: Somatotropin---1件: 65 💬
589NutropinAq 10mg/2ml solution for injection1件: Somatotropin---1件: 96 💬
590NutropinAq®1件: Somatotropin---1件: 96 💬
591Nuvion®)----1件: 97 💬
592NV1205----1件: 20 💬
593NVF233----1件: 13 💬
594NW-1015----1件: 6 💬
595NW-1015E, EMD 1195686, MSC2191632B----1件: 6 💬
596NX-13 250 mg----1件: 97 💬
597NX-13 250mg IR----1件: 97 💬
598NX-13 500mg IR----1件: 97 💬
599NX-13 500mg MR----1件: 97 💬
600NX1011----1件: 86 💬
601NYX-458----1件: 6 💬
602Nébivolol----1件: 113 💬